๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of ursodeoxycholic acid (UDCA) on patients with type I autoimmune hepatitis

โœ Scribed by Nakamura, K.; Yoneda, M.; Tamori, K.; Kimura, A.; Kato, T.; Yokohama, S.; Akiyama, K.; Saito, H.; Fujita, M.; Baba, K.; Makino, I.


Book ID
122557838
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
171 KB
Volume
108
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of ursodeoxycholic acid (UDCA) o
โœ E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 347 KB

The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u